4DMedical Limited (ASX:4DX)
Australia · Delayed Price · Currency is AUD 3.640
0.00 (0.00%)
Aug 28, 2026, 4:10 PM AEST
4DMedical Income Statement
Financials in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
| 7.06 | 5.85 | 3.75 | 0.72 | 1.05 | |
Revenue Growth | 20.64% | 55.91% | 422.45% | -31.84% | 385.90% |
Cost of Revenue | 0.44 | 0.46 | 0.24 | 0.03 | 0.77 |
Gross Profit | 6.62 | 5.39 | 3.52 | 0.68 | 0.28 |
Selling, General & Admin | 39.24 | 32.1 | 27.83 | 23.74 | 19.21 |
Other Operating Expenses | 19.44 | 15.46 | 16.65 | 18.95 | 16.32 |
Operating Expenses | 64.14 | 52.89 | 48.55 | 45.25 | 37.03 |
Operating Income | -57.51 | -47.5 | -45.03 | -44.57 | -36.75 |
Interest Expense | -164.61 | -0.26 | -0.26 | -0.29 | -0.18 |
Interest & Investment Income | 1.75 | 0.34 | 1.24 | 0.61 | 0.09 |
Currency Exchange Gain (Loss) | - | -0.6 | 0.35 | -0.03 | -0.03 |
Other Non Operating Income (Expenses) | 14.81 | 18.51 | 10.97 | 13.15 | 12.32 |
EBT Excluding Unusual Items | -205.57 | -29.51 | -32.74 | -31.14 | -24.55 |
Merger & Restructuring Charges | - | -0.66 | -3.19 | - | - |
Gain (Loss) on Sale of Assets | - | 0.01 | - | - | - |
Pretax Income | -205.57 | -30.16 | -35.93 | -31.14 | -24.55 |
Income Tax Expense | -1.13 | -0.09 | 0.05 | 0.32 | 0.04 |
Net Income | -204.44 | -30.07 | -35.98 | -31.46 | -24.59 |
Net Income to Common | -204.44 | -30.07 | -35.98 | -31.46 | -24.59 |
Net Income Growth | - | - | - | - | - |
Shares Outstanding (Basic) | 6,815 | 424 | 370 | 300 | 295 |
Shares Outstanding (Diluted) | 6,815 | 424 | 370 | 300 | 318 |
Shares Change | 1506.13% | 14.52% | 23.49% | -5.59% | 12.14% |
EPS (Basic) | -0.03 | -0.07 | -0.10 | -0.10 | -0.08 |
EPS (Diluted) | -0.03 | -0.14 | -0.11 | -0.10 | -0.08 |
EPS Growth | - | - | - | - | - |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Free Cash Flow | -32.22 | -34.56 | -31.02 | -23.07 | -27.92 |
Free Cash Flow Per Share | -0.01 | -0.08 | -0.08 | -0.08 | -0.09 |
Gross Margin | 93.77% | 92.07% | 93.69% | 95.25% | 26.62% |
Operating Margin | -814.47% | -811.49% | -1199.53% | -6202.49% | -3485.78% |
Profit Margin | -2895.06% | -513.72% | -958.34% | -4378.05% | -2332.63% |
Free Cash Flow Margin | -456.34% | -590.45% | -826.34% | -3211.05% | -2647.86% |
EBITDA | -52.06 | -46.05 | -43.88 | -43.83 | -36.34 |
D&A For EBITDA | 5.46 | 1.45 | 1.16 | 0.74 | 0.41 |
EBIT | -57.51 | -47.5 | -45.03 | -44.57 | -36.75 |